The diabetic antigen Glutamic acid decarboxylase (GAD 65) in the human peripheral blood

International Archives of Allergy and Immunology

Volumn 152, Issue 2, 2010, Pages 184-194

  Tilz, G P ^a,b   Dausset, J ^a   Wiltgen, M ^b  

^a Centre d'Etude du Polymorphysme Humain   (France)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Autoimmunity; Diabetes mellitus type 1; Fluorescence correlation spectroscopy; GAD 65; Glutamic acid decarboxylase; Molecular visualization

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE 65; MEMBRANE LIPID; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; FEMALE; FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN; HYDROPHOBICITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; JOB'S SYNDROME; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SPECTROMETRY, FLUORESCENCE; THYROIDITIS, AUTOIMMUNE;

EID: 72049094328     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265540     Document Type: Article

References (47)

1. Bach JF: The genetic determinism of polygenic diseases. Bull Acad Natl Med 1989;173:387-393; discussion 393-395.
2. Veleminsky Sr M, Buresova G: Health-related quality of life of children and adolescents with type 1 diabetes. Neuro Endocrinol Lett 2008;5:29.
3. Codner E, Cassorla F: Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm Res 2008;71:12-21.
4. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Gyula Soltész G; the EURODIAB Study Group: Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033.
5. Tong JC, Myers MA, Mackay IR, Zimmet PZ, Rowley MJ: The PEVKEK region of the pyridoxal phosphate binding domain of GAD 65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann NY Acad Sci 2002;958:182-189.
6. Tree TI, Morgenthaler NG, Duhindan N, Hicks KE, Madec AM, Scherbaum WA, Banga JP: Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by type I diabetic autoantibodies. Diabetologia 2000;43:881-889.
7. Eigen M, Rigler R: Sorting single molecules: application to diagnostics and evolutionary biotechnology. Proc Natl Acad Sci USA 1994;91:5740-5747.
8. Werner A, Konarev PV, Svergun DI, Hahn U: Characterization of a fluorophore binding RNA aptamer by fluorescence correlation spectroscopy and small angle X-ray scattering. Anal Biochem 2009;389:52-62.
9. Dittrich P, Malvezzi-Campeggi F, Jahnz M, Schwille P: Accessing molecular dynamics in cells by fluorescence correlation spectroscopy. Biol Chem 2001;382:491-494.
10. Schwille P: Fluorescence correlation spectroscopy and its potential for intracellular applications. Cell Biochem Biophys 2001;34:383-408.
11. Medina MA, Schwille P: Fluorescence correlation spectroscopy for the detection and study of single molecules in biology. Bioessays 2002;24:758-76 4.
12. Schlaman HR, Schmidt K, Ottenhof D, van Es MH, Oosterkamp TH, Spaink HP: Analysis of interactions of signaling proteins with phage-displayed ligands by fluorescence correlation spectroscopy. J Biomol Screen 2008;13:766-776.
13. Foldes-Papp Z, Demel U, Tilz GP: Ultrasensitive detection and identification of fluorescent molecules by FCS: impact for immunobiology. Proc Natl Acad Sci USA 2001;98:11509-11514.
14. Foldes-Papp Z, Demel U, Tilz GP: Detection of single molecules: solution-phase singlemolecule fluorescence correlation spectroscopy as an ultrasensitive, rapid and reliable system for immunological investigation. J Immunol Methods 2002;260:117-124.
15. Foldes-Papp Z, Demel U, Tilz GP: A new concept for ultrasensitive fluorescence measurements of molecules in solution and membrane. 2. The individual immune molecule. J Immunol Methods 2004;286:13-20. (Pubitemid 38490393)
16. Guex N, Peitsch MC: Swiss-Model and the Swiss-Pdb Viewer: An environment for comparative protein modelling. Electrophoresis 1997;18:2714-2723.
17. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The PDB data uniformity project. Nucleic Acids Res 2000;28:235-242.
18. Rigler R: Brownian motion of single molecules in electric fields. Electrophoresis 2002;23:805-808.
19. Pramanik A, Olsson M, Langel U, Bartfai T, Rigler R: Fluorescence correlation spectroscopy detects galanin receptor diversity on insulinoma cells. Biochemistry 2001;40:10839-10845.
20. Bach JF: Control of autoreactive T cell activation by immunoregulatory T cells (ART). Adv Exp Med Biol 2001;490:67-77.
21. Barbosa J, Bach FH: Cell-mediated autoimmunity in type I diabetes. Diabetes Metab Rev 1987;3:981-1004.
22. Lohmann T, Londei M, Hawa M, Leslie RD: Humoral and cellular autoimmune responses in stiff person syndrome. Ann NY Acad Sci 2003;998:215-222.
23. Timsit J, Debray-Sachs M, Boitard C, Bach JF: Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: in vitro characterization and time course study. Clin Exp Immunol 1988;73:260-264.
24. Chen B H, Chung SB, Chiang W, Chao MC: GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus. Diabetes Res Clin Pract 2001;54:27-32.
25. Davenport C, Radford PM, Al-Bukhari TA, Lai M, Bottazzo GF, Todd I: Hetero geneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmue polyendocrine patients with islet cell antibodies. Clin Exp Immunol 1998;111:497-505.
26. Jun. HS, Khil LY, Yoon JW: Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes. Cell Mol Life Sci 2002;59:1892-1901.
27. Mimura T, Funatsu H, Uchigata Y, Kitano S, Shimizu E, Amano S, Yamagami S, Noma H, Araie M, Hori S: Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy. Ophthalmology 2005;112:1904-1909.
28. Mohan V, Deepa R, Bhatia E, Singh AK, Hitman GA, Zimmet PZ, MacKay IR: Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particularreference to fibrocalculous pancreatic diabetes. Diabet Med 1998;15:156-159.
29. Tuomi T, Bjorses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A: Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1996;81:1488-1494. (Pubitemid 26118581)
30. Fenalti G, Law RH, Buckle AM, Langendorf C, Tuck Rosado CJ, Faux NG, Mahmood K, Hampe CS, Banga JP, Wilce M, Schmidberger J, Rossjohn J, El-Kabbani O, Pike RN, Smith AI, Mackay IR, Rowley MJ, Whisstock JC: GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Struct Mol. Biol 2007;14:280-286.
31. Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157:105-132.
32. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A: Protein identification and analysis tools on the ExPASy server; in Walker JM (ed): The Proteomics Protocols Handbook. Totowa, Humana Press, 2005, pp 571-607.
33. Schwartz HL, Chandonia JM, Kash SF, Kanaai J, Tunnell E, Domingo A, Cohen F, Banga JP, Madec AM, Richter W, Baekkeskov S: High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 1999;287:983-999.
34. Myers MA, Fenalti G, Gray R, Scealty M, Tong JC, El-Kabbani O, Rowley MJ: A diabetes-related epitope of GAD 65: a major diabetes-related conformational epitope on GAD 65. Ann NY Acad Sci 2003;1005:250-252.
35. Hummel M, Bonifacio E, Naserke HE, Ziegler AG: Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects. Diabetes Care 2002;25:1111-1116.
36. Maugendre D, Sonnet E, Derrien C, Le Golff MC, Grais MC, Allannic H, Delamaire M: Combined analysis of long-term anti-betacell humoral reactivity in type 1 diabetes with and without thyroid disease. Diabetes Metab 1999;25:28-33.
37. Paronen J, Klemetti P, Kantele JM, Savilahti E, Perheentupa J, Akerblom HK, Vaarala O: Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor α4β7-integrin. Diabetes 1997;46:583-588.
38. Bach JF, Chatenoud L: Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 2001;19:131-161.
39. Chatenoud L, Thervet E, Primo J, Bach JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994;91:123-127.
40. Koczwara K, Bonifacio E, Ziegler AG: Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 2004;53:1-4.
41. Fourlanos S, Perry C, Stein M, Stankovich JU, Harrison LC, Colman P: A Clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 2006;29:970-975.
42. Harrison LC: Risk assessment, prediction and prevention of type 1 diabetes. Pediatric Diabetes 2001;2:71-82.
43. Harrison LC: Vaccination against self to prevent autoimmune disease: the type 1 diabetes model: Immunol Cell Biol 2008;86:139-145.
44. Battin J: The prevention of rhesus hemolytic disease with anti-D 7-globulin. Cah Méd 1970;11:1099-1104.
45. Borst-Eilers E: Prevention of hemolytic disease of the newborn using anti-rhesus (D) γ-globulin. Maandschr Kindergeneeskd 1969;37:243-251.
46. MacKenzie IZ, Bichler J, Mason GC, Lunan CB, Stewart P, Al-Azzawi F, De Bono M, Watson N, Andresen I: Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin. Eur J Obstet Gynecol Reprod Biol 2004;117:154-161.
47. Mascola JR: Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine 2002;20:1922-1925.